Literature DB >> 1174034

DNA complexing antibiotics: daunomycin, adriamycin and their derivatives.

A Marco, F Arcamone.   

Abstract

9-Acetyl-4-methoxy-7,8,9,11-tetrahydroxy-6,7,9,11-tetrahydroxy-o-(3'-amino-2',3',6'-trideoxy-alpha-L-lyxohexopyranoside) (daunomycin, daunorubicin, NSC-82 131, Daunoblasin), 14-hydroxy-daunorubicin (adriamycin, doxorubicin, NSC-123 127, Adriblastin), dihydrodaunomycin, their aglycones and other related compounds represent the group of S. peucetius derived antibiotics. The biosynthetic glycosides as well as some semisynthetic analogues or derivatives form strong complexes with double stranded DNA, which can be understood in terms of the known intercalation model. A clear relationship is found between the complex forming ability and the biological activity of the different compounds. The structure and configuration of the sugar moiety appear of primary importance for the stabilization of the complex and, therefore, for action. A class of side chain derivatives, namely adriamycin 14-0-esters, looks promising. Different tissue distribution of such derivatives may result in new useful anticancer drugs.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174034

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  17 in total

Review 1.  Animal models in pediatric surgery.

Authors:  A Mortell; S Montedonico; P Puri
Journal:  Pediatr Surg Int       Date:  2005-12-06       Impact factor: 1.827

2.  Studies on the production of daunomycinone-derived glycosides and related metabolites in Streptomyces coeruleorubidus and Streptomyces peucetius.

Authors:  M Blumauerová; J Matĕjů; K Stajner; Z Vanĕk
Journal:  Folia Microbiol (Praha)       Date:  1977       Impact factor: 2.099

3.  The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patients.

Authors:  M A Graham; D R Newell; B J Foster; A H Calvert
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Comparative effects of adriamycin and DNA-non-binding analogues on DNA, RNA, and protein synthesis in vitro.

Authors:  M Israel; J M Idriss; Y Koseki; V K Khetarpal
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 5.  Streptomycetes producing daunomycin and related compounds: do we know enough about them after 25 years?

Authors:  J Huk; M Blumauerova
Journal:  Folia Microbiol (Praha)       Date:  1989       Impact factor: 2.099

6.  Induction of chromosomal aberrations by the anthracycline antitumor antibiotics N,N-dimethyldaunomycin and aclacinomycin A.

Authors:  G Steinheider; J Westendorf; H Marquardt
Journal:  Experientia       Date:  1987-05-15

7.  Clinical and pharmacologic studies with adriamycin-DNA complex in children with malignant disease.

Authors:  S O Lie; K K Lie; A Glomstein
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 8.  Anthracyclines.

Authors:  Z Vanĕk; J Tax; I Komersová; P Sedmera; J Vokoun
Journal:  Folia Microbiol (Praha)       Date:  1977       Impact factor: 2.099

9.  Comparative studies on phenol-soluble nonhistone chromatin proteins in normal and leukaemic human leukocytes.

Authors:  S Seeber; T Meshkov; K P Brucksch; J Käding; C G Schmidt; H Busch
Journal:  Klin Wochenschr       Date:  1979-03-15

10.  ABH antigenicity of in situ carcinoma of the urinary bladder during intracavity treatment with doxorubicin hydrochloride.

Authors:  G Jakse; F Hofstädter
Journal:  Urol Res       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.